Kilitch Drugs (India) Limited
NSE:KILITCH.NS
311.95 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | 2013 Q4 | 2013 Q3 | 2013 Q2 | 2013 Q1 | 2012 Q4 | 2012 Q3 | 2012 Q2 | 2012 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 334.516 | 448.188 | 317.945 | 412.022 | 365.57 | 454.771 | 299.723 | 306.97 | 334.527 | 366.075 | 344.313 | 235.705 | 196.249 | 199.32 | 203.274 | 180.72 | 101.917 | 116.231 | 159.299 | 153.351 | 104.319 | 191.665 | 84.173 | 268.209 | 280.852 | 38.14 | 36.081 | 60.448 | 55.604 | 70.188 | 13.117 | 28.81 | 36.866 | 71.873 | 34.488 | 65.096 | 154.319 |
Cost of Revenue
| 220.913 | 280.569 | 169.887 | 202.055 | 170.113 | 255.458 | 136.477 | 154.029 | 201.626 | 204.813 | 209.974 | 129.614 | 109.933 | 114.192 | 101.375 | 85.275 | 72.23 | 61.623 | 91.185 | 73.657 | 64.39 | 99.075 | 45.932 | 165.451 | 171.223 | 37.289 | 16.116 | 15.283 | 26.825 | 66.522 | 7.511 | 7.82 | 19.363 | 70.655 | 18.13 | 56.186 | 128.896 |
Gross Profit
| 113.603 | 167.619 | 148.058 | 209.967 | 195.457 | 199.313 | 163.246 | 152.941 | 132.901 | 161.262 | 134.339 | 106.091 | 86.316 | 85.128 | 101.899 | 95.445 | 29.687 | 54.608 | 68.114 | 79.694 | 39.929 | 92.59 | 38.241 | 102.758 | 109.629 | 0.851 | 19.965 | 45.165 | 28.779 | 3.666 | 5.606 | 20.99 | 17.503 | 1.218 | 16.358 | 8.91 | 25.423 |
Gross Profit Ratio
| 0.34 | 0.374 | 0.466 | 0.51 | 0.535 | 0.438 | 0.545 | 0.498 | 0.397 | 0.441 | 0.39 | 0.45 | 0.44 | 0.427 | 0.501 | 0.528 | 0.291 | 0.47 | 0.428 | 0.52 | 0.383 | 0.483 | 0.454 | 0.383 | 0.39 | 0.022 | 0.553 | 0.747 | 0.518 | 0.052 | 0.427 | 0.729 | 0.475 | 0.017 | 0.474 | 0.137 | 0.165 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 70.58 | 70.808 | 25.234 | 53.99 | 71.792 | 61.891 | 27.894 | 16.357 | 15.669 | 15.706 | 48.425 | 43.835 | 14.149 | 13.223 | 11.546 | 15.258 | 14.313 | 13.986 | 13.344 | 52.138 | 10.391 | 14.542 | 13.816 | 12.107 | 7.594 | 8.36 | 7.894 | 10.537 | 0 | 0 | 0 | -59.595 | 16.777 | 23.022 | 16.704 |
Selling & Marketing Expenses
| 0 | 0 | 29.611 | 26.849 | 26.886 | 54.284 | 21.876 | 20.764 | 17.316 | 13.337 | 12.022 | 15.199 | 14.755 | 24.535 | 7.617 | 7.658 | 5.02 | 26.064 | 9.551 | 8.599 | 12.488 | 16.465 | 21.32 | 24.202 | 6.406 | 8.038 | 3.481 | 2.424 | 4.792 | 26.188 | 0 | 0 | 0 | 12.666 | 0 | 0 | 0 |
SG&A
| 105.525 | 106.139 | 100.191 | 97.657 | 52.12 | 108.274 | 93.668 | 82.655 | 45.21 | 29.694 | 27.691 | 30.905 | 63.18 | 68.37 | 21.766 | 20.881 | 16.566 | 41.322 | 23.864 | 22.585 | 25.832 | 68.603 | 31.711 | 38.744 | 20.222 | 60.75 | 11.075 | 10.784 | 12.686 | 67.331 | 7.145 | 6.343 | 6.08 | -57.729 | 16.777 | 23.022 | 16.704 |
Other Expenses
| 25.738 | 4.712 | 29.561 | 4.891 | 5.625 | 10.204 | 6.866 | 2.396 | 9.714 | -22.69 | 13.091 | 1.681 | 10.538 | -9.801 | 3.684 | 4.221 | 3.695 | -24.868 | 6.897 | 5.863 | 13.779 | -45.456 | 3.274 | 19.216 | 23.767 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 132.72 | -6.764 | -12.483 | -20.351 |
Operating Expenses
| 105.525 | 106.139 | 133.407 | 131.938 | 141.565 | 146.325 | 132.715 | 122.28 | 106.928 | 111.834 | 128.693 | 76.499 | 81.72 | 81.441 | 76.714 | 70.828 | 45.664 | 79.742 | 58.78 | 67.087 | 51.606 | 18.162 | 79.001 | 63.526 | 82.258 | 33.791 | 29.106 | 35.398 | 26.045 | 44.034 | 11.035 | 12.163 | 0.812 | 74.991 | 10.013 | 10.539 | -3.647 |
Operating Income
| 8.078 | 61.48 | 44.212 | 82.92 | 53.892 | 63.192 | 37.397 | 33.057 | 25.973 | 60.322 | 5.646 | 29.592 | 19.351 | 28.222 | 32.802 | 32.275 | -10.957 | -10.957 | 18.885 | 21.206 | 0.811 | 90.893 | -19.44 | 63.434 | 33.777 | -10.279 | -16.196 | 3.662 | -3.885 | -41.086 | -4.825 | -1.746 | -2.837 | -73.773 | 6.345 | -1.629 | 29.07 |
Operating Income Ratio
| 0.024 | 0.137 | 0.139 | 0.201 | 0.147 | 0.139 | 0.125 | 0.108 | 0.078 | 0.165 | 0.016 | 0.126 | 0.099 | 0.142 | 0.161 | 0.179 | -0.108 | -0.094 | 0.119 | 0.138 | 0.008 | 0.474 | -0.231 | 0.237 | 0.12 | -0.27 | -0.449 | 0.061 | -0.07 | -0.585 | -0.368 | -0.061 | -0.077 | -1.026 | 0.184 | -0.025 | 0.188 |
Total Other Income Expenses Net
| 8.423 | -8.511 | -15.987 | -15.089 | -9.369 | -12.07 | -12.885 | -17.519 | 2.999 | -24.467 | 10.741 | 0.45 | -5.492 | -16.522 | -5.146 | -5.221 | -4.257 | -4.917 | -4.356 | -4.38 | -0.219 | -77.127 | -18.046 | -4.986 | 17.361 | -2.565 | 7.055 | 6.105 | 6.619 | 15.698 | 14.418 | 10.573 | 20.534 | 78.629 | 21.037 | -0.434 | -0.317 |
Income Before Tax
| 16.501 | 52.969 | 28.225 | 67.831 | 44.523 | 51.122 | 24.512 | 15.538 | 28.972 | 35.856 | 16.387 | 30.042 | 13.859 | 11.7 | 27.656 | 27.054 | -15.214 | -15.874 | 14.529 | 16.826 | 0.592 | 13.766 | -37.486 | 58.448 | 51.138 | -12.844 | -9.141 | 9.767 | 2.734 | -25.388 | 9.593 | 8.827 | 17.697 | 4.856 | 6.345 | -2.063 | 28.753 |
Income Before Tax Ratio
| 0.049 | 0.118 | 0.089 | 0.165 | 0.122 | 0.112 | 0.082 | 0.051 | 0.087 | 0.098 | 0.048 | 0.127 | 0.071 | 0.059 | 0.136 | 0.15 | -0.149 | -0.137 | 0.091 | 0.11 | 0.006 | 0.072 | -0.445 | 0.218 | 0.182 | -0.337 | -0.253 | 0.162 | 0.049 | -0.362 | 0.731 | 0.306 | 0.48 | 0.068 | 0.184 | -0.032 | 0.186 |
Income Tax Expense
| 15.382 | 16.162 | 10.809 | 16.895 | 13.928 | 22.11 | 7.431 | -3.827 | 11.602 | 12.859 | 10.258 | 4.228 | 6.663 | 4.615 | 5.817 | 4.975 | -1.877 | -3.402 | 5.079 | 3.449 | 2.527 | 8.807 | 10.669 | 16.373 | 11.719 | 0.869 | 1.638 | 3.571 | 2.25 | 6.934 | 1.51 | 4.289 | 0 | -0.271 | 21.037 | 0.2 | 0 |
Net Income
| 13.403 | 35.942 | 29.093 | 47.41 | 33.571 | 35.634 | 23.707 | 24.278 | 20.862 | 28.981 | 11.249 | 21.565 | 11.877 | 7.086 | 22.146 | 20.817 | -13.337 | -12.472 | 9.45 | 13.377 | -1.935 | 4.959 | -48.155 | 42.075 | 39.419 | -13.713 | -7.503 | 13.338 | 4.984 | -18.454 | 8.083 | 4.538 | 17.697 | 5.126 | 6.345 | -2.263 | 28.753 |
Net Income Ratio
| 0.04 | 0.08 | 0.092 | 0.115 | 0.092 | 0.078 | 0.079 | 0.079 | 0.062 | 0.079 | 0.033 | 0.091 | 0.061 | 0.036 | 0.109 | 0.115 | -0.131 | -0.107 | 0.059 | 0.087 | -0.019 | 0.026 | -0.572 | 0.157 | 0.14 | -0.36 | -0.208 | 0.221 | 0.09 | -0.263 | 0.616 | 0.158 | 0.48 | 0.071 | 0.184 | -0.035 | 0.186 |
EPS
| 0.83 | 2.24 | 1.81 | 2.95 | 2.15 | 2.29 | 1.52 | 1.56 | 1.34 | 1.86 | 0.72 | 1.39 | 0.76 | 0.46 | 1.43 | 1.34 | -0.86 | -0.81 | 0.62 | 0.87 | -0.13 | 0.32 | -3.33 | 3.01 | 2.57 | -1.03 | -0.57 | 1.01 | 0.38 | -1.39 | 0.61 | 0.34 | 1.31 | 0.33 | 0.48 | -0.18 | 2.17 |
EPS Diluted
| 0.83 | 2.24 | 1.81 | 2.95 | 2.15 | 2.29 | 1.52 | 1.56 | 1.34 | 1.86 | 0.72 | 1.39 | 0.76 | 0.46 | 1.43 | 1.34 | -0.86 | -0.8 | 0.62 | 0.87 | -0.13 | 0.32 | -3.33 | 3.01 | 2.57 | -1.03 | -0.57 | 1.01 | 0.38 | -1.39 | 0.61 | 0.34 | 1.31 | 0.33 | 0.48 | -0.17 | 1.98 |
EBITDA
| 16.589 | 70.771 | 52.36 | 91.086 | 67.408 | 72.335 | 46.668 | 41.923 | 43.914 | 54.253 | 20.703 | 38.253 | 19.575 | 18.351 | 33.881 | 33.796 | -7.427 | -8.328 | 22.107 | 22.978 | 6.465 | 38.288 | -32.262 | 63.497 | 55.857 | -5.746 | -12.786 | 7.073 | -0.475 | -37.487 | -1.867 | 1.212 | 0.121 | 6.509 | 9.628 | 1.751 | 32.45 |
EBITDA Ratio
| 0.05 | 0.158 | 0.165 | 0.221 | 0.184 | 0.159 | 0.156 | 0.137 | 0.131 | 0.148 | 0.06 | 0.162 | 0.1 | 0.092 | 0.167 | 0.187 | -0.073 | -0.072 | 0.139 | 0.15 | 0.062 | 0.2 | -0.383 | 0.237 | 0.199 | -0.151 | -0.354 | 0.117 | -0.009 | -0.534 | -0.142 | 0.042 | 0.003 | 0.091 | 0.279 | 0.027 | 0.21 |